Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
November 28, 2018
Sierra Oncology to Host Analyst Call Highlighting Clinical Data on Momelotinib's Anemia Benefit
VANCOUVER , Nov. 27, 2018 /CNW/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing targeted therapeutics for the treatment ...
November 28, 2018
Prometic Provides Corporate Update
LAVAL, QC , Nov 28, 2018 /CNW Telbec/ -  Prometic Life Sciences Inc. (PLI.TO) (PFSCF)("Prometic" or the "Corporation") has previously announced a series of initiatives to ...
November 28, 2018
Mustang Bio Announces Presentation of MB-102 (CD123 CAR) Safety and Efficacy Data at AACR Special Conference on Tumor Immunology and Immunotherapy
NEW YORK, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (MBIO), a company focused on the development of novel immunotherapies based on proprietary ...
November 28, 2018
BioTime Announces Distribution of AgeX Therapeutics Shares
BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that the registration statement on Form 10, including ...
November 28, 2018
InspireMD Announces Regulatory and Reimbursement Approval of CGuard™ Embolic Prevention System in Australia
TEL AVIV, Israel, Nov. 28, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention ...
November 27, 2018
OSE Immunotherapeutics Receives Belgian Authorization for a Phase 1 Clinical Trial to Evaluate Anti-IL-7 Receptor Antagonist OSE-127
NANTES, France, Nov. 26, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA(ISIN: FR0012127173; Mnémo: OSE) today announced authorization by Federal Agency for Medicines and Health Products (FAMH) ...
November 27, 2018
iCAD Unveils ProFound AI™ for Digital Breast Tomosynthesis at RSNA 2018
NASHUA, N.H. and CHICAGO, Nov. 26, 2018 (GLOBE NEWSWIRE) -- (Booth #3911 and #8161) – iCAD, Inc. (ICAD), a global medical technology leader providing innovative cancer ...
November 27, 2018
Tyme Technologies, Inc. to Present at the Piper Jaffray Healthcare Conference on November 28th
NEW YORK, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (TYME), a clinical stage biotechnology company developing cancer therapeutics to address multiple tumor types, ...
November 27, 2018
Molecular Templates to Present at the Evercore ISI and BMO Healthcare Conferences
AUSTIN, Texas, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (MTEM), a clinical-stage oncology company focused on the discovery and development of the company’s ...
November 27, 2018
Arrowhead Pharmaceuticals to Webcast 2018 Fiscal Year End Results
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that it will host a webcast and conference call on December 11, 2018, at 4:30 p.m. EST ...
November 27, 2018
Theravance Biopharma Announces First Subject Dosed in Phase 1 Clinical Trial of TD-8236, a Novel Inhaled pan-JAK Inhibitor
DUBLIN, Nov. 27, 2018 /PRNewswire/ -- Theravance Biopharma, Inc. (TBPH) ("Theravance Biopharma" or the "Company") today announced dosing of the first subject in a Phase ...
November 27, 2018
Paratek Pharmaceuticals Doses First Patient in Phase 2 Clinical Trial of Omadacycline in Acute Pyelonephritis, a Common Subset of Complicated Urinary Tract Infections
BOSTON, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today ...
November 27, 2018
Aileron Enters Clinical Trial Collaboration with Pfizer to Evaluate ALRN-6924 in Combination with IBRANCE® (palbociclib) in MDM2-Amplified Cancers
WATERTOWN, Mass., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (ALRN), the clinical-stage leader in the field of stabilized, cell-permeating peptides to treat cancer and ...
November 27, 2018
BrainsWay: TMS Associates of Pennsylvania First Facility in the State to Treat Obsessive-Compulsive Disorder (OCD) with Deep Transcranial Magnetic Stimulation (Deep TMS)
HAVERFORD, Pa., Nov. 27, 2018 (GLOBE NEWSWIRE) -- TMS Associates of Pennsylvania LLC, Haverford’s leading mental health provider specializing in mood disorders, announced today that ...
November 27, 2018
Foamix Announces Appointment of Matt Wiley as Chief Commercial Officer
REHOVOT, Israel, and BRIDGEWATER, N.J., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX), a clinical stage specialty pharmaceutical company focused on developing and ...
November 27, 2018
Publication of manuscript on preclinical Proof-of-Concept of arimoclomol in Gaucher disease
Copenhagen, November 27, 2018 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced that a manuscript ...
November 27, 2018
MannKind Appoints Christine Mundkur to its Board of Directors
WESTLAKE VILLAGE, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD) today announced that Christine Mundkur has joined its Board of Directors, effective November ...
November 27, 2018
Altimmune Appoints Vipin K. Garg, Ph.D. as its New President and Chief Executive Officer
GAITHERSBURG, Md., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced the appointment of Vipin K. Garg, Ph.D. as ...
November 19, 2018
Foamix Announces Appointment of Anthony Bruno to Board of Directors
REHOVOT, Israel and BRIDGEWATER, N.J., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX), a clinical stage specialty pharmaceutical company focused on developing and ...
November 19, 2018
Anchiano Therapeutics Reports Third Quarter 2018 Financial and Operational Results
CAMBRIDGE, Mass., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Anchiano Therapeutics (ANCN.TA), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to ...
Page 4 of 117